Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 73
Number of items: 73
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 2 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673815.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 14 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673806.v1
  • Soleimani Dodaran, M., Borgoni, S., Sofyall, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & Van Kampen, A. H. C. (2020). Additional file 3 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.12673818.v1
  • Open Access
    Soleimani Dodaran, M., Borgoni, S., Sofyali, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer. BMC Cancer, 20, Article 676. https://doi.org/10.1186/s12885-020-07100-z
  • Open Access
    Borgoni, S., Sofyali, E., Soleimani, M., Wilhelm, H., Müller-Decker, K., Will, R., Noronha, A., Beumers, L., Verschure, P. J., Yarden, Y., Magnani, L., van Kampen, A. H. C., Moerland, P. D., & Wiemann, S. (2020). Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer. Cancers, 12(10), Article 2918. https://doi.org/10.3390/cancers12102918
  • Open Access
    Herzog, K., Pras-Raves, M. L., Ferdinandusse, S., Vervaart, M. A. T., Luyf, A. C. M., van Kampen, A. H. C., Wanders, R. J. A., Waterham, H. R., & Vaz, F. M. (2018). Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics. Journal of inherited metabolic disease, 41(3), 479-487. https://doi.org/10.1007/s10545-017-0076-9
  • Open Access
    Herzog, K., Pras-Raves, M. L., Ferdinandusse, S., Vervaart, M. A. T., Luyf, A. C. M., van Kampen, A. H. C., Wanders, R. J. A., Waterham, H. R., & Vaz, F. M. (2018). Plasma lipidomics as a diagnostic tool for peroxisomal disorders. Journal of inherited metabolic disease, 41(3), 489-498. https://doi.org/10.1007/s10545-017-0114-7
  • Open Access
    Smith, R. L., Tan, J. M. E., Jonker, M. J., Jongejan, A., Buissink, T., Veldhuijzen, S., van Kampen, A. H. C., Brul, S., & van der Spek, H. (2017). Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity. PLoS ONE, 12(11), Article e0187424. https://doi.org/10.1371/journal.pone.0187424
  • Open Access
    Reshetova, P. V. (2017). Use of prior knowledge in biological systems modelling. [Thesis, fully internal, Universiteit van Amsterdam].
  • Herzog, K., Pras-Raves, M. L., Vervaart, M. A. T., Luyf, A. C. M., van Kampen, A. H. C., Wanders, R. J. A., Waterham, H. R., & Vaz, F. M. (2016). Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios. Journal of Lipid Research, 57(8), 1447-1454. https://doi.org/10.1194/jlr.M067470
Page 3 of 8